Cargando…
17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression
Estrogen replacement therapy increases the risk of human ovarian cancer and exogenous estradiol accelerates the onset of ovarian cancer in mouse models. This study uses primary cultures of mouse ovarian surface epithelium (OSE) to demonstrate that one possible mechanism by which estrogen accelerates...
Autores principales: | Vuong, Nhung H., Salah Salah, Omar, Vanderhyden, Barbara C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5711839/ https://www.ncbi.nlm.nih.gov/pubmed/29196616 http://dx.doi.org/10.1038/s41598-017-16219-2 |
Ejemplares similares
-
Single-cell RNA-sequencing reveals transcriptional dynamics of estrogen-induced dysplasia in the ovarian surface epithelium
por: Vuong, Nhung H., et al.
Publicado: (2018) -
17β-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo
por: Laviolette, Laura A, et al.
Publicado: (2014) -
Non-canonical WNT5a regulates Epithelial-to-Mesenchymal Transition in the mouse ovarian surface epithelium
por: Abedini, Atefeh, et al.
Publicado: (2020) -
GREB1 is an estrogen receptor-regulated tumour promoter that is frequently expressed in ovarian cancer
por: Hodgkinson, Kendra, et al.
Publicado: (2018) -
Transcriptional heterogeneity of stemness phenotypes in the ovarian epithelium
por: Carter, Lauren E., et al.
Publicado: (2021)